Warning issued to Brits with GHIC or EHIC amid expiry dates
The EHIC was replaced by the GHIC but are still in use with some Brits still having valid ones.
GHIC and EHIC cards allow you to receive state healthcare in another country (in the European Economic Area – EAA) 'on the same basis as a resident in that country', the NHS explains.
But, before you travel, you'll need to make sure your GHIC or EHIC is still valid and if not, it will need to be renewed so you can use it if needed.
Warning issued to everyone with a GHIC or EHIC
Nearly two million UK-issued EHIC and GHIC health cards will expire in 2025, putting travellers at risk of losing access to free or reduced-cost emergency healthcare when visiting Europe.
The importance of these cards is also underlined in new NHS data shared with travel insurance provider Holidaysafe.
It reveals that the UK has spent more than £800 million since 2016 to cover the cost of medical treatment for UK travellers abroad.
The new figures were obtained by Holidaysafe following a Freedom of Information (FOI) request.
The data from the NHS Business Services Authority (NHSBSA) shows that 1,960,640 health cards, including European Health Insurance Cards (EHICs), Global Health Insurance Cards (GHICs) and UK EHICs issued under the Withdrawal Agreement, will expire this year.
If you didn't know, your entitlement to UK Global Health Insurance GHIC is still valid in the EU/Switzerland. Europe is Europe. Not everything can be taken away after #Brexit. Renew if expired. It's still free of charge. Just renewed mine. Only EU colours & sign no longer exist. pic.twitter.com/wmt4YgCKtb — 🇬🇳🇬🇧 Alhoussein Fadiga #Peace&Love (@kipe76) January 11, 2025
'Many people don't even realise their card is expiring,' said Amber Moon, Holidaysafe Brand Manager.
She added: 'You could end up facing a bill of hundreds or even thousands of pounds for treatment that would otherwise have been covered. Renewing your GHIC is free and takes just minutes via the official NHS website.
'Having valid travel insurance and a GHIC or EHIC card can help you access emergency medical treatment and avoid unexpected costs if you fall ill or have an accident abroad. However, it's important to check what your travel insurance policy covers.'
Under reciprocal healthcare agreements, the UK government covers the cost of treatment abroad when a valid GHIC or EHIC is presented for medical care.
Can you still use a red passport in 2025?
In 2019, just before the pandemic, the bill for this care was £127.3 million. While it has since fallen, the total cost from 2016 to April 2025 now exceeds £813 million.
A spokesperson for the Foreign, Commonwealth and Development Office (FCDO) said: 'You can use your UK European/Global Health Insurance Card for any medically necessary care at a public hospital or medical centre in Europe.
'But whilst a valid GHIC/EHIC can help, it won't cover everything. Always check what's included in your travel insurance before travelling abroad and while your EHIC remains valid in the EU, replace it with a GHIC when it expires.'
Amber Moon added: 'When you look at how much the UK has paid out to cover medical bills abroad, it just highlights how important it is for people to carry a GHIC or to make sure they get one when their EHIC expires this year.'
Do you still need travel insurance with a GHIC or EHIC?
Travel insurance is still needed even if you have a GHIC or EHIC. While these cards entitle you to receive emergency medical treatment in Europe on the same terms as a local, they don't cover repatriation if you need to return to the UK - something that's included in many travel insurance policies.
They also won't cover you if you fall ill on a cruise or require rescue during a winter sports holiday.
Your passport is your most important travel document - it's worth taking your time to get right!
Before submitting your application check:
- your photo meets all requirements
- all personal details are correct
- supporting documents are ready
- payment details are accurate pic.twitter.com/mkzLHN5ZpY — His Majesty's Passport Office (@HM_Passport) June 16, 2025
How to check if your GHIC or EHIC is still valid
If you already have a GHIC or EHIC, you'll need to make sure it's valid before your trip.
To find out when it expires, check the expiry date box in the bottom right corner of the card. This will give you an exact date that it expires.
How to renew a GHIC or EHIC
If you have checked the expiry date and need to renew your card, it's free and easy to do via the NHS website.
Recommended reading:
You can renew your card up to nine months before yours runs out.
Once your EHIC expires, you will receive a GHIC when you renew it.
For those who don't already have one, you can apply for a new one which will last five years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
an hour ago
- Times
Assura-PHP merger looks in good health
As health checks for the UK's shrinking stock market go, it's hard to beat the bid battle for Assura: the real estate investment trust (Reit) whose 603 buildings house GP surgeries and private hospitals. So, this is just what the doctor ordered: an overdue admission from the board, chaired by Ed Smith, that there's plenty of listed life in the patient yet. Having been leant on by a bunch of Assura investors, it's switched its recommendation to the £1.79 billion cash-and-shares offer from Assura's main quoted rival, Primary Health Properties. And, yes, it took a tiny boost to the dose of about 2 per cent to convince Smith & co to do it. PHP is now offering 0.3865 new shares, up from 0.3769, for each of Assura's, plus an extra 0.84p special dividend to go with the same-again 12.5p-a-share cash: a figure totting up to 53.3p a share, at least before the merger arbs sent PHP shares down 4 per cent to 99.2p. Yet, while that cut the premium to the 'best and final' 50.42p cash bid from the infrastructure duo of KKR and Stonepeak to just 2.5 per cent, the choice for long-term investors has been clear for weeks. All KKR and Stonepeak are offering is a cash exit at Assura's net asset value of 50.4p a share at a cyclical low in the property market: scant reward for 22 years building its portfolio. It never looked enough to cash out. • NHS landlord Assura backs £1.7bn merger with rival PHP By contrast, PHP is offering a 48 per cent stake, plus a share in £9 million of synergies, in a bigger quoted healthcare Reit: one whose prospects are now being enhanced by lower interest rates and a spending review bringing an extra £29 billion a year for the NHS. Shareholders with about 15 per cent, including Schroders, Quilter Cheviot, Columbia Threadneedle, Aberdeen, Allianz and Baillie Gifford, have said they'll back PHP's bid: a point they've made clear to Smith and the senior independent director Jonathan Davies. Indeed, the bigger puzzler is why the board sided for so long with KKR and Stonepeak. Yes, Assura shares were at a big discount to NAV, but the board still batted away four efforts from KKR, banging on about 'the long-term prospects of the company' — only to roll over in March at the fifth attempt for a pittance more. And, then, when PHP provided a long-term alternative at a higher price, the board trashed it, parroting stuff from KKR and its adviser Jefferies. In fact, it's miraculous how 2 per cent extra can make all the board's concerns about 'elevated leverage', 'refinancing obligations', 'asset disposals' and 'integration risks' simply go away. Still, it got there in the end, with Smith saying PHP had 'addressed some of the potential risks that Assura had previously raised'. He'd argue, too, that, by banking a final offer from the cash bidders at a 39 per cent premium, he squeezed a bit more out of PHP. • PHP adds £27m dividend to its bid to merge with Assura Whatever, with Assura shares standing at 49¾p, PHP's chairman Harry Hyman and the former Wolverhampton Wanderers professional footballer turned chief executive, Mark Davies, will know this game isn't yet won. Assura's recommendation is key to landing passive investors, holding about 20 per cent, who typically take their cue from the board. But merger arbs hold 15 per cent more, while KKR and Stonepeak have bought 5 per cent of the shares. And, while both bids are structured as offers needing only majority support, PHP's is vulnerable to market shocks, not least over Iran. All the same, at least the right bidder is now in front. It was in his warm-up act as business secretary that the ex-chancellor Kwasi Kwarteng scrapped Britain's 'industrial strategy'. He declared it a 'pudding without a theme' — unlike his famous mini-budget, of course, which turned out to be a pudding with an unexploded bomb inside it. Still, in 14 years in power, Kwarteng was not really an outlier. None of the Tories' ten business secretaries delivered anything resembling a joined-up industrial strategy. Is Labour off to a better start? Well, there's always a danger in politicians trying to pick winners. And it's chosen eight sectors: defence, advanced manufacturing, clean energy, life sciences, technology, the creative industries and professional and financial services. Yet, at least, it's homed in on a key issue: if we don't cut our electricity costs for energy-intensive businesses, which last year 'paid twice the European average', we won't have any industry left. • Keir Starmer unveils 'targeted, long-term' industrial strategy Hence a plan to reduce electricity bills by up to 25 per cent by 2027 for 7,000-plus businesses, spanning the chemicals, aerospace and steel industries, while also speeding up their connections to the grid. How will the government cut their costs by £35 to £40 per megawatt hour? Mainly by letting them off green levies and via more alignment with the EU carbon market, at a cost of about £2 billion over four years. Still, it does beg a key question. If we're letting some of the most polluting businesses off the green charges, what about everyone else? And how long before the government brings in those long-awaited reforms to the system that will stop electricity prices being set by the marginal price of gas? It's time there was a strategy for that. A triple whammy so far this month for KKR: pulling the plug on Thames Water, behind in the battle for Assura, and now outranked by Advent in the £3.8 billion bid for Spectris: an agreed deal whose 84.6 per cent premium tells you all you need to know about UK market mispricing. KKR says it's 'actively engaged' in a potential counterbid for Spectris — and the shares closed at £37.98, above the £37.63 offer price. But fail to deliver and KKR could be looking at a quick UK hat-trick of lost deals.
The Guardian
2 hours ago
- The Guardian
Ex-Sky News presenter Dermot Murnaghan reveals stage 4 prostate cancer diagnosis
The former BBC and Sky News presenter Dermot Murnaghan has been diagnosed with prostate cancer. The 67-year-old announced his diagnosis on social media, saying it was one of stage four advanced cancer. Murnaghan said he was 'fortunate to have a simply outstanding medical team' looking after him that was 'administering the best possible care with expertise, compassion and sensitivity … I'm responding positively to their excellent treatment, and feeling well.' He added: 'Needless to say, my message to all men over 50, in high risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS. 'Early detection is crucial. And be aware, this disease can sometimes progress rapidly without obvious symptoms.' Stage four prostate cancer means that the disease has spread into different parts of the body including nearby organs, such as the back passage or bladder, nearby lymph nodes and other parts of the body outside the pelvis, such as the bones, lungs or liver, according to the Cancer Research UK website. Murnaghan, who spent more than 15 years at Sky News before his departure in 2023, said he was aiming to take part in Sir Chris Hoy's fundraising charity bike ride in September, which will raise awareness and funds for cancer charities across the UK. Hoy, the six-time Olympic gold medallist, announced he had a terminal diagnosis for prostate cancer in October 2024. Murnaghan presents true crime documentary series Killer Britain and the podcast Legends of News. He presented ITV's News at Ten and the BBC Ten O'Clock News – now known as BBC News at Ten – as well as Channel 4 News. Murnaghan also hosted the BBC's quiz programme Eggheads. About one in eight men will get prostate cancer in their lifetime, according to the charity Prostate Cancer UK, and the disease often has no symptoms in its earlier stages.
The Sun
2 hours ago
- The Sun
Why NHS fat jab rollout won't solve UK obesity crisis – but YOU will still end up paying as yo-yo porkers get hooked
TRUST me, I'm not a doctor. But as the first national newspaper journalist to investigate fat jabs, (and, in so doing, vomit in a Waitrose bag for life on a packed commuter train) I DO know what I'm talking about. 10 So believe me, the mass roll-out of weight-loss jabs isn't the great health revolution Big Pharma promises. The only true victors, at present, are Big Pharma. The plan to let GPs prescribe Mounjaro to those with a BMI over 40 and at least four other health problems — such as Type 2 diabetes or high blood pressure — is whacking a plaster on a severed arm. Or, indeed, a safety pin on the bulging seams of a fatty's waistband. These are miracle drugs. But they address the problem, NOT the cause. And obesity, as so many will testify, is as much an emotional problem as physical. Where is the help for people who use food as a crutch? No one chooses to stuff themselves with doughnuts 24/7. Unless there's a longer-term strategy, one prioritising prevention over quick-fix cure, we shall go from being a nation of porkers to a nation of yo-yo porkers; 'healthy' one month, obese again five months after the jabs have stopped. In other words, the majority of people will need to be on them for life. (Or 'lifers', as one celeb WhatsApp group is named, consisting entirely of those micro-dosing Mounjaro). GPs, who already claim they're overworked, won't have the time to give every patient a dedicated exercise and diet plan. Getting lean isn't a one-size-fits-all programme. The fear, then, is that the grossly overweight will be able to plop on their sofas, merrily jabbing once a week — at taxpayer expense — waiting for the lard to drop off. The same foods that got them here — invariably ultra-processed, fried — are still consumed. Just less of them. That's not healthy — it is simply scratching that McDonald's itch with a Quarter Pounder instead of a Big Mac. Natural desire Unless people exercise concurrently, once the weight is off, they'll be left with uncomfortable excess skin. In April 2023, during a trip to Los Angeles (where A-listers have been on Wegovy, Mounjaro and Ozempic since 2018) I tried out all three pens. I wrote about the experience, warning of the deeply unpleasant side effects. In five months I lost around 8kg, dropping to a tiny size 8. I hadn't weighed so little since I was at university. I looked amazing, bar a touch of 'Ozempic Face'. And — with the exception of Mounjaro for which there were blessedly few side effects — I felt horrific. I was sick, repeatedly (once, a nadir, under a table in First Class on a heaving rush hour train), once on a treadmill (jogging) and on one occasion I visibly retched while on a Zoom call to a Hollywood actress. Plus my eyes went blurry, prompting a quick visit to Moorfields Eye Hospital. 'No pain no gain' has its limits. Anyway, convinced I'd have entirely reprogrammed my brain — one that thinks about my next snack the very nanosecond it stirs in the morning — I came off them. And promptly shot up a dress size. I write this as someone who knows how to eat, and goes to the gym come hell or hangover five days a week. But still I battle daily my natural desire to smash a kilo of peanut butter and eat delicious olive-oily pasta daily. Fat jabs are 100 per cent a miracle drug. But they do not address the emotional side of eating (or drinking) that so, so many Brits suffer with. Of course there are exceptions: those who use the jabs positively to break the pattern, kick-starting a fantastic lifestyle overhaul. But they're the exceptions. Unless we want a bunch of 'lifers', the NHS MUST use these drugs with caution, and start developing a weaning-off process. At present, there is none. And that must change. IT'S ALL WHITE NOW… THREE months is a long time in showbusiness. Back in spring, Rachel Zegler 's disastrous turn as Snow White – which saw her slagging off the original film for being 'weird' and sexist promptly after getting the million pound big break – had her on the verge of cancellation. Today she's being feted on a daily basis, and lauded as the most exciting West End talent in decades. Playing Evita at the London Palladium, each night huge crowds are gathering on the street to see this young superstar belt out Don't Cry For Me Argentina. She is, by all accounts, mind-blowingly good. MINISTERS spent more than £500,000 of taxpayers' money on a new makeover of the Government website. And the 'makeover' in question? 10 From this . . . To this . . . Yep, the black to blue refresh, with a dot placed approx two millimetres higher up, is what your hard-earned dollar is paying for. Cool. SOUND POLICY IDEA of the week. Should Keir, Kemi or Nige fancy a guaranteed vote-winner, whack this on the next election manifesto. Anyone caught playing music/TV/video games on their tablet/smartphone on public transport, minus headphones should receive an automatic prison sentence. Genuinely, is there ANYTHING more annoying? HOST'S RIGHT ON CUE 10 KUDOS to Martine Croxall. The BBC News presenter calmly overrode the corporation's pathetically woke autocue, correcting it from a bulletin about 'pregnant people' to 'women'. Martine is a previous winner of Celebrity Mastermind, which explains it. Unlike the silly young fool who writes BBC News scripts. MUCH kerfuffle surrounding the Assisted Dying Bill finally getting passed last week. Why? For me, it's really very simple. We treat our aged, ill and cherished pets with love, respect and kindness towards the end of life, we should do the same for ourselves. It won't result in hundreds of thousands of dead-before-their-time OAP's being perfidiously wiped out by greedy grandkids; it will simply mean fewer people dying in greater pain. TAKING CARE OF MYSELFIE OBVIOUSLY I'm a sucker for a trend. Like a lemming to a cliff edge, off I trot to try out what the cool kids do – which is how I stumbled upon the latest-ish TikTok fad for putting a selfie into Chat GPT and asking it what you'd look like under different circumstances. So off I ventured, instructing my virtual friend to tell me what I'd look like in five years time if I 'smoked 40 a day' and 'didn't moisturise'. The results, as you can see, weren't pretty. Next, I asked it how I'd fare if 'ate only whole foods, exercised five days a week, drank two litres of mineralised water, took weekly facials and had no stress in my life; the results were prettier, albeit somewhat insultingly it gave me an entirely new face. Finally, I asked Chat GPT to show me 12 stone portlier – see for yourselves. *Orders fat jab* BRAT'S WAY TO DO IT WHO says women's tennis isn't a patch on men's? Russian-born Yulia Putintseva, aka the sport's biggest brat, who last year taunted a ball girl, got in another spat after her third round match against Maria Sakkari at the Bad Homberg Open. After Putintseva refused to make eye contact while shaking hands, Sakkari told her to 'act like a human being', before adding, cuttingly: 'Nobody likes you'. Ms Putintseva promptly told her opponent to 'go f***' herself. Language which will go down a treat next week when Wimbledon starts.
